Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins
- PMID: 11051246
Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins
Abstract
Sporadic human pituitary tumors are benign adenomas of monoclonal origin. This implies that they arise from de novo somatic mutation(s) within a single pituitary cell. The availability of original and recurrent/regrown tumors from the same patient allowed testing of the prediction that recurrent/regrown tumors have identical genetic abnormalities as the original tumor sample. We used PCR amplification, from archival slide-extracted DNA, to allelotype microsatellite polymorphisms as an indication of clonality and confirmed this by X chromosome inactivation analysis in samples from women. Tumors from 33 of 49 (67%) patients with two or more specimens showed loss of heterozygosity (LOH) of at least one marker in at least one of their samples. Two patterns of LOH were observed. In pattern A in 14 of 33 (42%) of patients, the LOH pattern of the first tumor was preserved in the second recurrent sample, with some recurrent tumors also showing additional LOH. In these patients, the original and second tumors are presumed to arise from the same original clone with or without progressive accumulation of LOH. In pattern B [19 of 33 (58%) patients], LOH seen in the first tumor was not preserved in the second or subsequent tumors, as evidenced by retention of heterozygosity compared with the first tumor. The simplest explanation is that the second tumor, although still monoclonal, arises from another independently abnormal clone. This was confirmed by X chromosome inactivation analysis in all 11 women where this was informative. These results show that initial and recurrent tumors, of a benign tumor type, are frequently derived from separate independent clones. This suggests that either: (a) more than one abnormal clone is present from the outset though only one dominates; or (b) several clones arise independently at different times. In both scenarios, the initiating event(s) that predisposes to transformation might result in multiclonal hyperplasia, possibly as a consequence of exogenous stimulation.
Similar articles
-
Clonality of pituitary tumours: more complicated than initially envisaged?Brain Pathol. 2001 Jul;11(3):313-27. doi: 10.1111/j.1750-3639.2001.tb00402.x. Brain Pathol. 2001. PMID: 11414474 Free PMC article. Review.
-
Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.J Gastroenterol Hepatol. 2005 Apr;20(4):536-46. doi: 10.1111/j.1440-1746.2005.03609.x. J Gastroenterol Hepatol. 2005. PMID: 15836701
-
Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.Clin Cancer Res. 2005 Oct 15;11(20):7226-33. doi: 10.1158/1078-0432.CCR-04-2597. Clin Cancer Res. 2005. PMID: 16243792
-
Clonal origin of lymph node metastases in bladder carcinoma.Cancer. 2005 Nov 1;104(9):1901-10. doi: 10.1002/cncr.21466. Cancer. 2005. PMID: 16196038
-
Pituitary tumour clonality revisited.Front Horm Res. 2004;32:186-204. doi: 10.1159/000079045. Front Horm Res. 2004. PMID: 15281347 Review.
Cited by
-
Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies.BMC Med Genet. 2013 Jan 23;14:12. doi: 10.1186/1471-2350-14-12. BMC Med Genet. 2013. PMID: 23343470 Free PMC article.
-
Clonality of pituitary tumours: more complicated than initially envisaged?Brain Pathol. 2001 Jul;11(3):313-27. doi: 10.1111/j.1750-3639.2001.tb00402.x. Brain Pathol. 2001. PMID: 11414474 Free PMC article. Review.
-
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.Cold Spring Harb Mol Case Stud. 2017 May;3(3):a001602. doi: 10.1101/mcs.a001602. Cold Spring Harb Mol Case Stud. 2017. PMID: 28487882 Free PMC article.
-
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2.Pituitary. 2024 Jun;27(3):248-258. doi: 10.1007/s11102-024-01385-0. Epub 2024 Mar 14. Pituitary. 2024. PMID: 38483762 Free PMC article.
-
Somatotropes maintain their immature cells through Insulin-like growth factor I (IGF-I).Endocr Pathol. 2007 Fall;18(3):174-81. doi: 10.1007/s12022-007-0016-6. Endocr Pathol. 2007. PMID: 18058266
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical